ASGCT News

July 12: Abstract Deadline for Advancing Gene + Cell Therapies for Cancer

Send us your research through July 12 | June 28, 2024

Send us your research for the chance to present it at the event this fall.

Read Full Story

AAV Capsid Production with Drs. Mario Mietzsch and Robert McKenna

Molecular Therapy Podcast | June 18, 2024

Listen today on the ASGCT Podcast Network!

Molecular Therapy  |  Podcasts

Read Full Story

Maria Santaella, PhD (c), MSN, RN-BC, CPHON serves as the Vice President of Research for the National Bleeding Disorders Foundation. During the workshop she spoke on clinical trial enrollment by sharing strategies to address barriers in recruiting.

Inclusive Trial Design Amplifies Patient Voices and Drives Meaningful Outcomes

Samuel Hughes, MBA, St. Jude Children's Research Hospital | June 18, 2024

Overcoming recruitment, endpoint, and resource challenges in rare disease trials was the focus of the workshop organized by the Patient Outreach Committee at the ASGCT 27th Annual Meeting.

Annual Meeting 2024  |  Outreach  |  Patient Perspectives  |  Policy & Advocacy

Read Full Story

Patient Advocates Connect at the Annual Meeting

Ali Kujawski, Senior Patient Outreach Manager | June 12, 2024

Patient advocates connected, learned from researchers, and shared experiences at ASGCT's 2nd Annual Patient Advocate Connection Luncheon, hosted at the ASGCT Annual Meeting, highlighting the Society's commitment to engaging the patient community.

Annual Meeting 2024  |  Policy & Advocacy

Read Full Story

Gene Insertion Tech with SalioGen CEO Jason Cole

ASGCT Podcast Network | June 11, 2024

SalioGen CEO Jason Cole joins host Emily Walsh Martin, PhD to explore the company's cutting-edge transposase-based gene insertion technology presented at the ASGCT Annual Meeting.

Podcasts

Read Full Story

Meet Catherine Gillespie: ASGCT Volunteer Spotlight

Dani Gale | June 04, 2024

Catherine Gillespie's passion for language and storytelling led her to the forefront of gene and cell therapy communications at ASGCT.

Volunteer Spotlight

Read Full Story

A New Vision for MTMCD with EiC Dr. Mohamed Abou-el-Enein

ASGCT Podcast Network | June 04, 2024

Mohamed Abou-el-Enein, MD, PhD, MSPH, the new editor-in-chief of Molecular Therapy Methods & Clinical Development (MTMCD), sits down with Scientific Editor Rory Bricker-Anthony, PhD, to discuss his vision for the journal.

Molecular Therapy  |  Podcasts

Read Full Story

FDA's Dr. Nicole Verdun and Julie Tierney to Speak at ASGCT's 2024 Policy Summit

May 29, 2024

Register today to hear from these influential FDA officials Sept. 23-24

Policy & Advocacy  |  Policy Summit

Read Full Story

ASGCT Urges Congress to Address Gene Therapy Access Hurdles

Margarita Valdez Martínez | May 24, 2024

ASGCT advocates for policies to ensure patient access to transformative cell and gene therapies, which can face coverage barriers in employer-sponsored insurance plans. Key issues include transparency around coverage decisions and flexibility to explore innovative payment models.

Policy & Advocacy

Read Full Story

ASGCT Members Lead Congressional Briefing on Gene Editing

May 24, 2024

A cohort of ASGCT members and leaders together delivered a Congressional briefing to educate the governing body on the potential for gene-edited therapies to address unmet needs.

Read Full Story

Congratulations to These #ASGCT2024 Poster Presenters

View the full abstract collection | May 17, 2024

We received more than 1,000 votes this year to determine these winners!

Annual Meeting 2024

Read Full Story

Enjoy the Final Day of #ASGCT2024!

Fill out our five-minute evaluation to let us know how we did! | May 11, 2024

Today, hear from our final oral abstract presenters and symposia speakers to close out the 27th Annual Meeting.

Read Full Story

Today: Global Outreach Committee Symposium, Final Fireside Chat, More Abstracts

Miss a session? Watch on demand for 30 days. | May 10, 2024

Later this morning, help us recognize our Outstanding New Investigator Award recipients!

Read Full Story

ASGCT Announces Joseph C. Glorioso, PhD, as Incoming Editor-in-Chief of Molecular Therapy

ASGCT & Molecular Therapy | May 09, 2024

Glorioso, a trailblazing gene therapy researcher and founding member of ASGCT, will assume the role on January 1, 2025.

Molecular Therapy

Read Full Story

Diversity, Equity, and Inclusion Within Gene and Cell Therapy: Where Does It Stand?

Christina Fuentes, PhD | May 09, 2024

Watch the DEI Committee's symposium on developing CGTs with a DEI-forward approach on the virtual platform if you missed it!

Annual Meeting 2024

Read Full Story

Hear from Drs. Beverly Davidson, Philip Gregory During Today's George Stam Lecture

Miss a session? Watch on demand for 30 days. | May 09, 2024

We're also looking forward to more symposia and oral abstracts, the second day of the Career Fair, and the Women in Gene + Cell Therapy reception.

Annual Meeting 2024

Read Full Story